If your email program has trouble displaying this email, view it as a web page.
Digital Health Update: New FDA Pre-Cert Working Model Now Available
Today the FDA issued a new Software Precertification (Pre-Cert) Pilot Program working model 1.0test plan, and regulatory framework. These documents explain how the FDA reimagined its way of regulating digital health devices by looking at information across the total product lifecycle.
In 2019, the Pilot program is entering its test phase. During this test phase, the FDA will assess whether the Excellence Appraisal and Streamlined Review components together produce an equivalent basis for determining reasonable assurance of safety and effectiveness for a software device prior to its introduction to the market, as compared to the traditional paradigm.
A healthcare professional using a tablet with healthcare icons superimposed over the image.
While the FDA’s goal with the Pre-Cert program is to regulate digital health technologies in a way that fosters innovation, the model is based in protecting patient safety.

Read More in the Documents Released Today

Stay Engaged

The FDA will host a user session on Thursday, February 7, 2019, to help clarify software developers’ questions about the Software Precertification (Pre-Cert) Pilot Program, including the Pre-Cert Working Model Version 1.0. The FDA encourages software developers to review the model, test plan, and regulatory framework before the session.

Thursday, February 7, 2019 | 1:00PM-2:30PM Eastern Time

No registration required.

To ensure you are connected, please dial-in 15 minutes before the start of the webinar. You must dial-in to hear the presentation and ask questions:

U.S. Callers Dial: 888-989-4611,
Conference Number: PWXW8564436; Passcode: 1805715

International Callers Dial: 1-415-228-4969;
Conference Number: PWXW8564436; Passcode: 1805715

To view the slide presentation during the webinar: https://www.mymeetings.com/nc/join.php?i=PWXW8564436&p=1805715&t=c

We appreciate your feedback on our webinar program. After the webinar, we will provide a link to a short survey, which should take no more than 5 to 10 minutes to complete. Your responses are confidential and will be used to improve the quality of our webinar program.


If you have questions about the Pre-Cert pilot program, please email fdapre-certpilot@fda.hhs.gov.

U.S. Food and Drug Administration
10903 New Hampshire Avenue, Silver Spring, MD 20993
1-888-INFO-FDA (1-888-463-6332)
Privacy Policy | www.fda.gov
Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists